Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
group | 0.400 | None | 0.947 | 57 | 1 | 1995 | 2018 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
group | 0.400 | None | 0.965 | 57 | 0 | 1999 | 2020 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.400 | None | 0.981 | 54 | 0 | 1998 | 2020 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
group | 0.400 | None | 0.904 | 52 | 5 | 1994 | 2018 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.400 | None | 1.000 | 51 | 0 | 2004 | 2019 | ||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.959 | 49 | 1 | 2007 | 2020 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.400 | None | 0.959 | 49 | 1 | 1989 | 2019 | ||||||||
|
mesothelin | 0.525 | 0.692 | 5.9E-25 |
|
group | 0.400 | None | 1.000 | 48 | 0 | 2005 | 2019 | ||||||||
|
BLM RecQ like helicase | 0.535 | 0.808 | 1.5E-15 |
|
group | 0.400 | None | 0.979 | 48 | 4 | 1999 | 2019 | ||||||||
|
aurora kinase A | 0.475 | 0.731 | 0.87 |
|
group | 0.400 | None | 0.979 | 48 | 2 | 2004 | 2020 | ||||||||
|
EPH receptor A2 | 0.501 | 0.731 | 1.1E-05 |
|
group | 0.400 | None | 1.000 | 47 | 0 | 2002 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.400 | None | 0.976 | 42 | 3 | 1997 | 2020 | ||||||||
|
lin-28 homolog A | 0.523 | 0.731 | 1.9E-02 |
|
group | 0.400 | None | 0.976 | 41 | 0 | 2009 | 2020 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
group | 0.400 | None | 0.975 | 40 | 0 | 2000 | 2019 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
group | 0.400 | None | 1.000 | 40 | 0 | 2005 | 2019 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
group | 0.400 | None | 1.000 | 40 | 0 | 1999 | 2020 | ||||||||
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
group | 0.400 | None | 1.000 | 39 | 1 | 1999 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
group | 0.400 | None | 0.946 | 37 | 1 | 2002 | 2019 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3B | 0.547 | 0.731 | 5.2E-16 |
|
group | 0.400 | None | 0.973 | 37 | 1 | 2001 | 2019 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
group | 0.400 | None | 1.000 | 36 | 0 | 1995 | 2020 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
group | 0.400 | None | 1.000 | 33 | 6 | 1997 | 2019 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
group | 0.400 | None | 1.000 | 32 | 0 | 2000 | 2019 | ||||||||
|
TNF receptor superfamily member 10a | 0.521 | 0.731 | 5.1E-15 |
|
group | 0.400 | None | 0.969 | 32 | 5 | 2000 | 2018 | ||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
group | 0.400 | None | 0.968 | 31 | 0 | 2003 | 2020 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
group | 0.400 | None | 0.903 | 31 | 1 | 1998 | 2019 |